Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Do H. Kim"'
Autor:
Robert W. Cross, Zachary A. Bornholdt, Abhishek N. Prasad, Viktoriya Borisevich, Krystle N. Agans, Daniel J. Deer, Dafna M. Abelson, Do H. Kim, William S. Shestowsky, Lioudmila A. Campbell, Elaine Bunyan, Joan B. Geisbert, Karla A. Fenton, Larry Zeitlin, Danielle P. Porter, Thomas W. Geisbert
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-10 (2021)
Extending the therapeutic window for acute viral infections could save lives. Here, the authors show that combination treatment with a human monoclonal antibody and remdesivir initiated at 6 days post infection with Marburg virus provides 80% protect
Externí odkaz:
https://doaj.org/article/d0f0bff00c684416a81ac789aecee0a8
Autor:
Robert W. Cross, Zachary A. Bornholdt, Abhishek N. Prasad, Courtney Woolsey, Viktoriya Borisevich, Krystle N. Agans, Daniel J. Deer, Dafna M. Abelson, Do H. Kim, William S. Shestowsky, Lioudmila A. Campbell, Elaine Bunyan, Joan B. Geisbert, Natalie S. Dobias, Karla A. Fenton, Danielle P. Porter, Larry Zeitlin, Thomas W. Geisbert
Publikováno v:
JCI Insight, Vol 7, Iss 10 (2022)
A major challenge in managing acute viral infections is ameliorating disease when treatment is delayed. Previously, we reported the success of a 2-pronged mAb and antiviral remdesivir therapeutic approach to treat advanced illness in rhesus monkeys i
Externí odkaz:
https://doaj.org/article/c92d002b9f334e558178cd3717ce240a
Publikováno v:
Oman Medical Journal, Vol 34, Iss 2, Pp 164-168 (2019)
Papillary cystadenocarcinomas (PCAs) are rare low-grade salivary gland tumors first introduced in the World Health Organization classification in 1991. While classically regarded as a low-grade malignancy, PCAs with more clinically and histologically
Externí odkaz:
https://doaj.org/article/554e74fd514142569c82f9e7bd27cc54
Autor:
Wang, Kevin Y.1, Do H. Kim2, Ya Xu2, Rad, Mohammad G.1 mdghrad@gmail.com, Lincoln, Christie M.1
Publikováno v:
Oman Medical Journal. Mar2019, Vol. 34 Issue 2, p164-168. 5p.
Autor:
Marnie L Fusco, Takao Hashiguchi, Robyn Cassan, Julia E Biggins, Charles D Murin, Kelly L Warfield, Sheng Li, Frederick W Holtsberg, Sergey Shulenin, Hong Vu, Gene G Olinger, Do H Kim, Kevin J Whaley, Larry Zeitlin, Andrew B Ward, Cory Nykiforuk, M Javad Aman, Jody D Berry, Erica Ollmann Saphire
Publikováno v:
PLoS Pathogens, Vol 11, Iss 10, p e1005212 (2015)
Externí odkaz:
https://doaj.org/article/2f7b06399f1047a9997e8c106e3d84e0
Autor:
Marnie L Fusco, Takao Hashiguchi, Robyn Cassan, Julia E Biggins, Charles D Murin, Kelly L Warfield, Sheng Li, Frederick W Holtsberg, Sergey Shulenin, Hong Vu, Gene G Olinger, Do H Kim, Kevin J Whaley, Larry Zeitlin, Andrew B Ward, Cory Nykiforuk, M Javad Aman, Jody D Berry, Erica Ollmann Saphire
Publikováno v:
PLoS Pathogens, Vol 11, Iss 6, p e1005016 (2015)
The filoviruses, which include the marburg- and ebolaviruses, have caused multiple outbreaks among humans this decade. Antibodies against the filovirus surface glycoprotein (GP) have been shown to provide life-saving therapy in nonhuman primates, but
Externí odkaz:
https://doaj.org/article/0eef54b956b34015946458e1d84e03e4
Publikováno v:
Oman Medical Journal, Vol 34, Iss 2, Pp 164-168 (2019)
Oman Medical Journal
Oman Medical Journal
Papillary cystadenocarcinomas (PCAs) are rare low-grade salivary gland tumors first introduced in the World Health Organization classification in 1991. While classically regarded as a low-grade malignancy, PCAs with more clinically and histologically
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::330e2a9d0f0e5f26fdfc26372c02a484
https://doi.org/10.5001/omj.2019.30
https://doi.org/10.5001/omj.2019.30
Autor:
Crystal L. Moyer, Rebekah M. James, John M. Dye, Ariel S. Wirchnianski, Xiangguo Qiu, Natasha Bohorova, Robert H. Bortz, Simon J. Anthony, Laura M. Walker, Guodong Liu, Zachary A. Bornholdt, Rohit K. Jangra, Zirui Zhang, Bronwyn M. Gunn, Wenjun Zhu, Eileen C. Goodwin, Tracey Goldstein, Michael H. Pauly, Andrew S. Herbert, Kevin J. Whaley, Larry Zeitlin, Anna Z. Wec, Do H. Kim, Ognian Bohorov, Galit Alter, Kartik Chandran, Shihua He, Jesus Velasco, Dafna M. Abelson, Russell R. Bakken
Passive administration of monoclonal antibodies (mAbs) is a promising therapeutic approach for Ebola virus disease (EVD). However, all mAbs and mAb cocktails that have entered clinical development are specific for a single member of the Ebolavirus ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b946571786c52a9fed01938861d404a7
https://europepmc.org/articles/PMC6396299/
https://europepmc.org/articles/PMC6396299/
Autor:
Ognian Bohorov, Lisa E. Hensley, Christopher Bartos, Gene G. Olinger, Michael R. Holbrook, Ralph S. Baric, Jeffrey Solomon, Joshua C. Johnson, Ulas Bagci, Jiusong Sun, Nicholas Oberlander, Daniel J. Mollura, Peter B. Jahrling, Larry Zeitlin, Xianchun Tang, Charles Goodman, Wayne A. Marasco, Louis Huzella, Natasha Bohorova, Kevin J. Whaley, James Pettitt, Reed F. Johnson, Michael H. Paulty, Quan Zhu, Britini L. Ork, Do H. Kim, Jing Qin, Lauren Keith, Jesus Velasco
Publikováno v:
Virology
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) was identified in 2012 as the causative agent of a severe, lethal respiratory disease occurring across several countries in the Middle East. To date there have been over 1600 laboratory confirme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::438d8f7ddf92f132d35a3f1789fcd48d
Autor:
Jesus Velasco, Robert W. Cross, Rebekah M. James, Galit Alter, Kartik Chandran, Niaz Rahim, Dafna M. Abelson, John M. Dye, Andrew S. Herbert, Kevin J. Whaley, Xiangguo Qiu, Michael H. Pauly, Shihua He, Do H. Kim, Logan Banadyga, Natasha Bohorova, Kevin Tierney, Viktoriya Borisevich, Anna Z. Wec, Eric Ailor, Laura M. Walker, Joan B. Geisbert, Eileen C. Goodwin, Chad E. Mire, Bronwyn M. Gunn, Wenjun Zhu, Ognian Bohorov, Thomas W. Geisbert, Zachary A. Bornholdt, William S. Shestowsky, Krystle N. Agans, Larry Zeitlin
All available experimental vaccines and immunotherapeutics1,2 against Ebola virus (EBOV), including rVSV-ZEBOV3 and ZMappTM4, lack activity against other ebolaviruses associated with human disease outbreaks. This year, two separate outbreaks of EBOV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c61c819d381e3e9deb68c869a4089e0
https://doi.org/10.1101/395533
https://doi.org/10.1101/395533